Related Experiment Video
Updated: Jun 14, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert Group.
Concetta Irace1, Angelo Avogaro2, Federico Bertuzzi3
1Department of Health Science, University Magna Græcia, Catanzaro, Italy.
Diabetes/Metabolism Research and Reviews
|June 11, 2025
Summary
Continuous glucose monitoring (CGM) offers improved glycaemic control and reduced hypoglycemia risk for type 2 diabetes (T2D) patients. This expert opinion reviews current evidence and suggests expanded practical uses for CGM in T2D management.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Care
Background:
- Type 2 diabetes (T2D) is a global pandemic with significant prognostic impact.
- Effective glycaemic control is challenged by poor adherence, self-management, and disease heterogeneity.
- Traditional capillary blood glucose monitoring has limitations for comprehensive diabetes self-management.
Purpose of the Study:
- To summarize current evidence on continuous glucose monitoring (CGM) in type 2 diabetes (T2D).
- To propose practical indications for CGM use beyond existing guidelines.
- To address the need for wider application of CGM in T2D management.
Main Methods:
- Review of existing scientific literature on CGM use in T2D.
- Expert opinion synthesis of current evidence and clinical experience.
- Analysis of CGM benefits across various T2D treatment regimens.
Main Results:
- CGM provides detailed glucose patterns, identifies glycemic extremes, and assesses control stability.
- CGM has demonstrated efficacy in improving glycaemic control and reducing hypoglycemia in type 1 diabetes (T1D).
- Emerging evidence supports CGM's utility in T2D, with potential for broader application.
Conclusions:
- CGM offers significant advantages over traditional monitoring for T2D patients.
- Expanded use of CGM in T2D can enhance self-management and clinical outcomes.
- Further research and guideline updates are warranted to optimize CGM integration in T2D care.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:15Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:15Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K